Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial

By afschroeder • August 26, 2025

Ashfaq A, Choe J, Strugnell SA, Patel N, Sprague SM, Norris KC, Lerma E, Petkovich PM, Bishop CW, Ashfaq A. Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial. Am J Nephrol. 2025;56(4):490-499. doi: 10.1159/000544086. Epub 2025 Feb 21. PMID: 39987904; PMCID: PMC12342699.

Tags: Chronic kidney disease, Extended-release calcifediol, General Internal Medicine, Parathyroid hormone, Progression, Publications, secondary hyperparathyroidism

Patient-reported discordance between care goals and treatment intent in advanced cancer

Shah MP, Wenger NS, Glaspy J, Hays RD, Sudore RL, Rahimi M, Gibbs L, Anand S, Tseng CH, Walling AM. Patient-reported discordance between care goals[...]

Ensuring Inclusive Governance for Trustworthy and Responsible AI Network

Bright TJ, Norris KC. Ensuring Inclusive Governance for Trustworthy and Responsible AI Network. JAMA. 2025 Aug 25. doi: 10.1001/jama.2025.11214. Epub ahead of print. PMID: 40853677.

Collagenous Gastritis in Adults: A Case Series Elucidating the Potential Overlap with Eosinophilic Gastritis

Shahrvini B, Wang HL, Weiss GA. Collagenous Gastritis in Adults: A Case Series Elucidating the Potential Overlap with Eosinophilic Gastritis. Dig Dis Sci. 2025 Aug[...]